Related Experiment Video
Updated: Aug 14, 2026
18:01
Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 19, 2008
Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator
1DOV Pharmaceutical, Inc., 433 Hackensack Avenue, Hackensack, NJ 07601, USA. alippa@dovpharm.com
Summary
Ocinaplon, a novel anxioselective agent, effectively treats generalized anxiety disorder without benzodiazepine-like side effects. This compound modulates GABA(A) receptors, offering a promising alternative for anxiety treatment.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Benzodiazepines are common anxiety disorder treatments but cause limiting side effects like sedation.
- An anxioselective agent, offering anxiolysis without these side effects, is needed for generalized anxiety disorder.
- Ocinaplon is a pyrazolo[1,5-a]-pyrimidine compound investigated for anxiolytic properties.
Purpose of the Study:
- To evaluate the anxioselective profile of ocinaplon in preclinical models and human clinical trials.
- To determine if ocinaplon provides anxiolytic effects comparable to benzodiazepines but with a reduced side effect profile.
Main Methods:
- Preclinical assessment in rats using the Vogel "conflict" test to determine effective dose and side effect threshold.
- In vitro studies using recombinant GABA(A) receptor isoforms to analyze ocinaplon's modulation mechanisms.
- A double-blind, placebo-controlled clinical trial in patients with generalized anxiety disorder to assess efficacy and safety.
Main Results:
- Ocinaplon demonstrated anxiolytic effects in rats at doses significantly lower than those causing sedation, muscle relaxation, or ataxia.
- Ocinaplon's anticonflict effect was blocked by flumazenil, indicating GABA(A) receptor modulation.
- Clinical trials showed ocinaplon significantly reduced anxiety scores (Hamilton rating scale) without an increased incidence of benzodiazepine-like side effects compared to placebo.
Conclusions:
- Ocinaplon exhibits an anxioselective profile, demonstrating efficacy in treating generalized anxiety disorder.
- The compound modulates GABA(A) receptors differently than traditional benzodiazepines, contributing to its unique side effect profile.
- Ocinaplon represents a novel therapeutic approach for anxiety disorders, warranting further investigation.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...